Abstract |
The study aims to investigate the potentially neuroprotective effects and underlying mechanisms for brown seaweed polysaccharide of polymannuronic acid (PM) against Parkinson's disease (PD) pathogenesis. PD model mice were pretreated with PM via oral gavage once per day for 4 weeks and the preventative effects of PM against neuronal loss together with its modulation on brain-gut-microbiota axis were systematically explored. The results showed PM administration improved motor functions by preventing dopaminergic neuronal loss in the substantia nigra pars compacta (SNpc) and enhanced contents of striatal homovanillic acid (HVA), serotonin (5-HT), 5-hydroxyindole acetic acid (5-HIAA) and γ- aminobutyric acid ( GABA) in PD mice. PM significantly alleviated inflammation in gut, brain and systemic circulation as shown by reduced levels or expressions of pro-inflammatory cytokines concurrently and inhibited mitogen-activated protein kinases (MAPK) signaling pathway in mice colon. Meanwhile, PM greatly improved integrity of intestinal barrier and blood brain barrier (BBB) as indicated by increased expressions of tight junction associated proteins in both mice colon and SNpc. Further studies indicated PM treatment resulted in changes of gut microbial compositions, together with great alterations of digestion and metabolism of dietary proteins and fats, which led to surge increase of fecal short chain fatty acids (SCFAs) in the colon of PD mice. In conclusion, pre-administration of PM could provide neuroprotective effects against PD pathogenesis by suppressing inflammation in gut, brain and systemic circulation, and by improving integrity of intestinal barrier and BBB. PM might modulate brain-gut-microbiota axis, at least in part, via gut microbiota derived SCFAs as mediators.
|
Authors | Xiao-Li Dong, Xiong Wang, Fang Liu, Xin Liu, Zhong-Rui Du, Robert W Li, Chang-Hu Xue, Ka-Hing Wong, Wing-Tak Wong, Qing Zhao, Qing-Juan Tang |
Journal | International journal of biological macromolecules
(Int J Biol Macromol)
Vol. 164
Pg. 994-1005
(Dec 01 2020)
ISSN: 1879-0003 [Electronic] Netherlands |
PMID | 32710966
(Publication Type: Journal Article)
|
Copyright | Copyright © 2020 Elsevier B.V. All rights reserved. |
Chemical References |
- Neuroprotective Agents
- RNA, Ribosomal, 16S
- Alginic Acid
|
Topics |
- Administration, Oral
- Alginic Acid
(pharmacology)
- Animals
- Blood-Brain Barrier
- Brain
(drug effects)
- Dopaminergic Neurons
(drug effects)
- Gastrointestinal Microbiome
- Inflammation
- Intestines
(chemistry)
- Male
- Mice
- Mice, Inbred C57BL
- Neuroprotective Agents
(pharmacology)
- Parkinson Disease
(drug therapy, metabolism)
- RNA, Ribosomal, 16S
(genetics)
- RNA-Seq
- Real-Time Polymerase Chain Reaction
|